Tag Archives: Canadian Securities Administration

Aphria Liberty Health sale agreement

Liberty Health Sciences Applauds CSA Notice Regarding Issuers With U.S. Cannabis Investments

Liberty Health Sciences Applauds CSA Notice Regarding Issuers With U.S. Cannabis Investments

TORONTO, Ontario, Feb. 9, 2018 /Weed Wire/ – Liberty Health Sciences Inc. (CSE: LHS or US OTCQX: LHSIF) (the “Company” or “Liberty”) is providing the following statement in response to the Canadian Securities Administration’s (the “CSA”) Staff Notice 51-352 Issuers with U.S. Marijuana-Related Activities (the “Notice”), revised February 8, 2018.


Top